LIDEMOL CREAM

Држава: Канада

Језик: Енглески

Извор: Health Canada

Активни састојак:

FLUOCINONIDE

Доступно од:

BAUSCH HEALTH, CANADA INC.

АТЦ код:

D07AC08

INN (Међународно име):

FLUOCINONIDE

Дозирање:

0.05%

Фармацеутски облик:

CREAM

Састав:

FLUOCINONIDE 0.05%

Пут администрације:

TOPICAL

Јединице у пакету:

15G/50G

Тип рецептора:

Prescription

Терапеутска област:

ANTI-INFLAMMATORY AGENTS

Резиме производа:

Active ingredient group (AIG) number: 0106313001; AHFS:

Статус ауторизације:

APPROVED

Датум одобрења:

1998-09-02

Карактеристике производа

PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
PR
LIDEMOL
®
Fluocinonide Cream USP
0.05% w/w
TOPICAL CORTICOSTEROID
BAUSCH HEALTH, CANADA INC.
DATE OF REVISION:
2150 St-Elzear Blvd. West
March 25, 2021
Laval, Quebec
H7L 4A8
Control #: 245941
LIDEMOL
®
is a trademark of Bausch Health Companies or its affiliates.
_Pr_
_LIDEMOL_
_®_
_ Product Monograph Page 2 of 22_
TABLE OF CONTENTS
TABLE OF CONTENTS
..............................................................................................................2
PART I: HEALTH PROFESSIONAL INFORMATION
..........................................................4
1
INDICATIONS
..................................................................................................................4
2
CONTRAINDICATIONS
.................................................................................................4
3
DOSAGE AND ADMINISTRATION
.............................................................................4
3.1
Recommended Dose and Dosage Adjustment
...........................................................4
4
OVERDOSAGE
.................................................................................................................4
5
DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING ................5
6
WARNINGS AND PRECAUTIONS
...............................................................................5
6.1
General
.......................................................................................................................5
6.2
Endocrine and Metabolism
........................................................................................5
6.3
Ophthalmic
.................................................................................................................6
6.4
Hepatic
.......................................................................................................................6
6.5
Immune
......................................................................................................................6
6.6
In